Gabriel-Stefan Nadj

Gabriel-Stefan Nadj

Auto-generated profile, based on publicly available information

Gabriel-Stefan Nadj

University Clinical Center of Vojvodina, Clinic of Gynecology and Obstetrics, Novi Sad + University of Novi Sad, Faculty of Medicine, Novi Sad

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2022 in Nature
Verified
Journal Article
Closed access
PDF file
TLTobias Lanz
Tobias Lanz
RBR. Camille Brewer
R. Camille Brewer
PHPeggy P. Ho
Peggy P. Ho
JMJae-Seung Moon
Jae-Seung Moon
KJKevin M. Jude
Kevin M. Jude
WRWilliam H. Robinson
William H. Robinson

11 January 2022 in Research Square
Verified
Preprint
Open access
PDF file
TLTobias Lanz
Tobias Lanz
RBR Camille Brewer
R Camille Brewer
PHPeggy P Ho
Peggy P Ho
KJKevin M Jude
Kevin M Jude
DFDaniel Fernandez
Daniel Fernandez
WRWilliam H Robinson
William H Robinson
Multiple sclerosis (MS) is a heterogenous autoimmune disease in which autoreactive lymphocytes attack the myelin sheath of the central nervous system (CNS). B lymphocytes in the cerebrospinal fluid (CSF) of MS patients contribute to inflammation and secrete oligoclonal immunoglobulins. Epstein-Barr virus (EBV) infection has been linked to MS epidemiologically, but its pathological role remains unclear. Here we demonstrate high-affinity molecular mimicry between the EBV transcription factor EBNA1 and the CNS protein GlialCAM, and provide structural and in-vivo functional evidence for its relevance. A cross-reactive CSF-derived antibody was initially identified by single-cell sequencing of the paired-chain B cell repertoire of MS blood and CSF, followed by protein microarray-based testing of recombinantly expressed CSF-derived antibodies against MS-associated viruses. Sequence analysis, affinity measurements, and the crystal structure of the EBNA1-peptide epitope in complex with the autoreactive Fab fragment allowed for tracking the development of the naïve EBNA1-restricted antibody to a mature EBNA1/GlialCAM cross-reactive antibody. Molecular mimicry is facilitated by a post-translational modification of GlialCAM. EBNA1 immunization exacerbates the mouse model of MS and anti-EBNA1/GlialCAM antibodies are prevalent in MS patients. Our results provide a mechanistic link for the association between MS and EBV, and could guide the development of novel MS therapies.

1 January 2024 in Medicinski Pregled
Verified
Journal Article
Open access
PDF file
MSMarko Sinisa Stojic
Marko Sinisa Stojic
MPMilos Pantelic
Milos Pantelic
JUJovan Ugarkovic
Jovan Ugarkovic
GNGabriel-Stefan Nadj
Gabriel-Stefan Nadj
AIAleksandra Ilić
Aleksandra Ilić
Introduction. Vulvar carcinoma is a rare gynecological malignancy, accounting for 0.6 percent of all female cancers. Case Report. A-76-year-old woman presented with a tumorous lesion in the lower third of the left labia majora and minora, measuring approximately 25 mm. A multifocal biopsy was conducted, and pelvic magnetic resonance imaging revealed slight enlargement of a left inguinal solid lymph node. The patient underwent a left hemivulvectomy with inguinofemoral lymphadenectomy. Histopathological analysis confirmed a malignant lentiginous tumor, and inguinofemoral lymphadenectomy revealed metastatic malignant melanoma. Despite a negative histopathological finding of the contralateral side during the initial biopsy, the patient returned within three months with a 9-mm mucosal nodular type melanoma on the lower third of the right labia majora. A wide excision of the vulva was subsequently performed. Following consultation with a multidisciplinary tumor board, adjuvant immunotherapy with Pembrolizumab (200 mg per cycle, 9 cycles) was initiated. Conclusion. Vulvar malignant melanoma is rare, aggressive, and unpredictable tumor that predominantly affects women in later life. It is associated with a high recurrence rate and a poor overall prognosis.

1 January 2026 in Medicinski Pregled
Verified
Journal Article
Closed access
PDF file
BJBojana Jovancevic
Bojana Jovancevic
AVAleksandra Vejnovic
Aleksandra Vejnovic
GNGabriel-Stefan Nadj
Gabriel-Stefan Nadj
AIAleksandra Ilić
Aleksandra Ilić
Introduction. Caesarean scar endometriosis is a rare form of abdominal wall endometriosis that develops following caesarean delivery as a result of ectopic implantation of endometrial tissue within the surgical scar. Patients typically present with cyclic pain and a palpable abdominal wall mass, although diagnosis may be challenging because it resembles other abdominal wall lesions. Case Report. A 31-year-old woman presented with painful nodules located within a previous Cohen laparotomy scar. Symptoms began approximately one year after caesarean delivery and were strongly associated with menstruation. Ultrasonography demonstrated multiple heterogeneous lesions within the scar. Surgical exploration revealed multifocal endometriosis involving the skin, subcutaneous tissue and fascia. Complete excision of all visible lesions was performed. Histopathological examination confirmed abdominal wall endometriosis by demonstrating endometrial glands and stroma associated with haemorrhage, haemosiderin-laden macrophages, and fibrosis. The postoperative course was uneventful, and satisfactory wound healing was observed at the two-week follow-up visit. Conclusion. This case illustrates an uncommon presentation of caesarean scar endometriosis characterised by multifocal disease and extensive abdominal wall involvement. Caesarean scar endometriosis should be considered in women with cyclic pain and a mass arising within a previous caesarean section scar. Early recognition and complete surgical excision remain essential for definitive diagnosis and effective treatment.

1 January 2026 in Medicinski Pregled
Verified
Journal Article
Closed access
PDF file
DBDaniel Bjelica
Daniel Bjelica
GNGabriel-Stefan Nadj
Gabriel-Stefan Nadj
ABArtur Bjelica
Artur Bjelica
Introduction. The digitalisation of healthcare systems has led to a rapid proliferation of cybersecurity threats that directly affect everyday clinical practice. Electronic health records, networked medical devices, and telemedicine platforms have become integral to modern medicine while simultaneously representing potential attack surfaces. Clinicians make daily decisions with data security implications, and inadequate training leaves them particularly vulnerable. Threats and vulnerabilities. Ransomware attacks that paralyse hospital systems, phishing campaigns targeting clinical staff, attacks on medical Internet of Things devices, and software supply chain compromise are the most prevalent threats in the contemporary healthcare environment. Each carries direct consequences for patient safety and continuity of care. Clinician roles and advanced technologies. Clinical staff represent both the most frequent point of system compromise and the most important line of defence. Advanced technologies including artificial intelligence based threat detection, blockchain data integrity, and federated learning offer emerging solutions, but require strategic institutional commitment for successful deployment. Conclusion. Cybersecurity is not exclusively an information technology matter - it is an integral component of medical ethics and responsibility towards patients. Its routine integration into clinical practice requires education, clear institutional procedures, and adequate resources.

1 January 2026
Verified
Journal Article
Closed access
DBDaniel Bjelica
Daniel Bjelica
TSTijana Stanivukovic
Tijana Stanivukovic
GNGabriel-Stefan Nadj
Gabriel-Stefan Nadj
David StrilićDavid Strilić
David Strilić
ABArtur Bjelica
Artur Bjelica
Introduction. Infertility represents a major global health challenge with profound medical, psychological, and social consequences. Despite substantial advances in assisted reproductive techniques, the success rates of in vitro fertilization remain limited, largely due to subjectivity in embryo selection and variability in ovarian stimulation management. Application of artificial intelligence in embryo selection. Artificial intelligence systems enable the analysis of large and complex datasets, including morphological and morphokinetic embryo characteristics derived from static imaging and continuous developmental monitoring. These approaches enhance the standardization of embryo quality assessment and reduce interobserver variability; however, their performance remains constrained by the quality of training data and the incomplete representation of biological determinants of implantation. Role of artificial intelligence in ovarian stimulation management. Algorithms integrating clinical, hormonal, and ultrasonographic parameters facilitate individualized gonadotropin dosing, more accurate determination of final oocyte maturation timing, and reduction of ovarian hyperstimulation risk. Existing studies demonstrate a high level of concordance between algorithm-based recommendations and expert clinical decision-making. Future directions. Further advancements are anticipated through the development of multimodal models integrating morphological, clinical, and genetic data, alongside the implementation of explainable systems to enhance transparency and clinical trust. Conclusion. Currently, artificial intelligence serves primarily as a decision-support tool rather than a substitute for clinical expertise. Its routine clinical implementation requires robust prospective validation and regulatory approval.